BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34621476)

  • 1. Evaluating the benefit of adjuvant chemotherapy in patients with ypT0-1 rectal cancer treated with preoperative chemoradiotherapy.
    Jeon YW; Park IJ; Kim JE; Park JH; Lim SB; Kim CW; Yoon YS; Lee JL; Yu CS; Kim JC
    World J Gastrointest Surg; 2021 Sep; 13(9):1000-1011. PubMed ID: 34621476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
    Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer.
    Park IJ; Kim DY; Kim HC; Kim NK; Kim HR; Kang SB; Choi GS; Lee KY; Kim SH; Oh ST; Lim SB; Kim JC; Oh JH; Kim SY; Lee WY; Lee JB; Yu CS
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):540-7. PubMed ID: 26068489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates.
    Oh SY; Park IJ; Kim YI; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
    Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
    World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
    Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
    Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
    Liao YT; Lin YL; Huang J; Hung JS; Lin BR
    Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy.
    Zhang H; Huang Y; Sun G; Zheng K; Lou Z; Gao XH; Hao LQ; Liu LJ; Meng RG; Zhang W
    Ann Transl Med; 2020 Jun; 8(12):743. PubMed ID: 32647668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
    Kim CG; Ahn JB; Shin SJ; Beom SH; Heo SJ; Park HS; Kim JH; Choe EA; Koom WS; Hur H; Min BS; Kim NK; Kim H; Kim C; Jung I; Jung M
    BMC Cancer; 2017 Sep; 17(1):615. PubMed ID: 28865435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma.
    Sisic L; Blank S; Nienhüser H; Haag GM; Jäger D; Bruckner T; Ott K; Schmidt T; Ulrich A
    Surg Oncol; 2020 Jun; 33():177-188. PubMed ID: 28684226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Responsiveness of Lymph Nodes to Preoperative Chemoradiotherapy in Patients With Rectal Cancer on Prognosis After Radical Resection.
    Lee HG; Kim SJ; Park IJ; Hong SM; Lim SB; Lee JB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e191-e199. PubMed ID: 31014994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
    Lu Z; Cheng P; Zhang MG; Wang XS; Zheng ZX
    Gastroenterol Rep (Oxf); 2018 Nov; 6(4):277-283. PubMed ID: 30430016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.
    Hwang K; Park IJ; Yu CS; Lim SB; Lee JL; Yoon YS; Kim CW; Kim JC
    World J Gastroenterol; 2015 Jan; 21(2):563-70. PubMed ID: 25593475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients with abdominoperineal resection (APR) and low anterior resection (LAR) who had very low rectal cancer.
    Yeom SS; Park IJ; Jung SW; Oh SH; Lee JL; Yoon YS; Kim CW; Lim SB; Kim N; Yu CS; Kim JC
    Medicine (Baltimore); 2017 Oct; 96(43):e8249. PubMed ID: 29068989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
    Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
    ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent "no tumor" status?
    Jeong SA; Park IJ; Hong SM; Bong JW; Choi HY; Seo JH; Kim HE; Lim SB; Yu CS; Kim JC
    Ann Surg Treat Res; 2019 Feb; 96(2):78-85. PubMed ID: 30746355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer.
    Park IJ; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JS; Park SH; Park JH; Kim JH; Yu CS; Kim JC
    Medicine (Baltimore); 2015 Dec; 94(52):e2377. PubMed ID: 26717384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer.
    Oh BY; Park YA; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY
    Ann Surg Treat Res; 2022 Oct; 103(4):235-243. PubMed ID: 36304190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.